Swiss National Bank Lowers Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Swiss National Bank trimmed its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 385,100 shares of the medical instruments supplier’s stock after selling 13,600 shares during the period. Swiss National Bank owned approximately 0.19% of DENTSPLY SIRONA worth $5,753,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. lifted its position in DENTSPLY SIRONA by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after acquiring an additional 557,329 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock valued at $238,186,000 after buying an additional 1,975,404 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 2.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after buying an additional 314,343 shares during the period. Lazard Asset Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 23.0% during the 4th quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier’s stock valued at $152,678,000 after buying an additional 1,505,928 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in DENTSPLY SIRONA by 21.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,851,869 shares of the medical instruments supplier’s stock worth $130,045,000 after purchasing an additional 1,230,944 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on XRAY. UBS Group decreased their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Barrington Research set a $18.00 price target on DENTSPLY SIRONA and gave the company an “outperform” rating in a report on Friday, August 8th. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a report on Friday, August 8th. Finally, Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Twelve analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $18.64.

DENTSPLY SIRONA Trading Up 0.1%

Shares of DENTSPLY SIRONA stock opened at $13.86 on Tuesday. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -2.92, a PEG ratio of 0.86 and a beta of 0.94. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.48. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The business has a 50-day moving average price of $15.41 and a 200-day moving average price of $15.61.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The firm’s revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the business posted $0.49 earnings per share. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.6%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA’s payout ratio is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.